Citanest and Vascular pseudoaneurysm - a phase IV clinical study of FDA data

Summary:

Vascular pseudoaneurysm is reported as a side effect among people who take Citanest (prilocaine hydrochloride), especially for people who are male, 40-49 old, also take Remeron, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Vascular pseudoaneurysm when taking Citanest. It is created by eHealthMe based on reports of 737 people who have side effects when taking Citanest from the FDA, and is updated regularly.

What is Citanest?

Citanest has active ingredients of prilocaine hydrochloride. eHealthMe is studying from 740 Citanest users. Check the latest studies of Citanest.

What is Vascular pseudoaneurysm?

Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity) is found to be associated with 269 drugs and 348 conditions by eHealthMe. Check the latest studies of Vascular pseudoaneurysm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

737 people reported to have side effects when taking Citanest.
Among them, 13 people (1.76%) have Vascular pseudoaneurysm.

Could Citanest cause Vascular pseudoaneurysm?

Among these 13 people:

What is the gender of people who have Vascular pseudoaneurysm when taking Citanest? *

female: 7.69 %
male: 92.31 %

What is the age of people who have Vascular pseudoaneurysm when taking Citanest? *

What are other drugs people take besides Citanest? *

What are other side effects people have besides Vascular pseudoaneurysm? *

Wound Decomposition: 13 people, 100.00%
Azotaemia (excess of urea or other nitrogenous compounds in the blood): 13 people, 100.00%
Fever: 13 people, 100.00%
Fluid Overload (too much fluid in the blood): 13 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 100.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 13 people, 100.00%
Gouty Arthritis (joint inflammation with crystal formation): 13 people, 100.00%
Gynecomastia (enlargement of the gland tissue of the male breast): 13 people, 100.00%
Hepatitis C: 13 people, 100.00%
High Blood Pressure: 13 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Citanest and have Vascular pseudoaneurysm?

- Check whether Vascular pseudoaneurysm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citanest:

Citanest (740 reports)

Browse all side effects of Citanest:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vascular pseudoaneurysm:

Vascular pseudoaneurysm (269 drugs)

Browse all the conditions that are associated with Vascular pseudoaneurysm:

Vascular pseudoaneurysm (348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prilocaine hydrochloride (the active ingredients of Citanest) and Citanest (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.